Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
A pipeline to multiplex Parkinson's disease iPSC-derived dopaminergic neurons and microglia for cohort-scale single-cell RNA sequencing
FY 2022-23
Summary
Parkinson's disease (PD) is the second most common neurodegenerative disease, presenting symptoms such as tremor and imbalance due to the loss of brain cells. Currently, no treatment exists for PD, but advancing technology continues to provide insight into the genetic basis of the disease. Here, I aim to develop a computational algorithm that facilitates the study of gene expression in PD for large sample sizes.
New technologies that differentiate pluripotent stem cells into specific cell types have advanced neurodegenerative disease research, but this differentiation process is currently unfeasible for large sample sizes. Pooling and differentiating cells from many samples in the same dish improves feasibility; however, the sample identity of all cells must then be determined. My algorithm will unravel the identity of pooled cells from unprecedented sample sizes.
As proof of principle, I will test the hypothesis that differentiating pooled cells, followed by gene expression analysis, can be used to determine transcriptional responses to chemical compounds in PD. Specifically, I will differentiate pooled cells from PD cases and controls into dopaminergic neurons or microglia. Then, I will treat the cells with chemical compounds that target known PD genetic pathways. Finally, I will use my algorithm to resolve each cell's identity and analyze differential gene expression between cases and controls.
My algorithm will make future single-cell gene expression analyses of large sample sizes feasible. Furthermore, I intend to show that the combination of my algorithm, pooled growth of patient-derived cells, and transcriptional analysis could be used to evaluate therapeutic compounds in PD, instituting the application of this methodology across neurodegenerative diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486340
Name
Fiorini Michael R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A pipeline to multiplex Parkinson's disease iPSC-derived dopaminergic neurons and microglia for cohort-scale single-cell RNA sequencing
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatic Pipeline; Biomarker; Dopaminergic Neurons; Gba; Induced Pluripotent Stem Cells; Lrrk2; Microglia; Multiplex; Parkinson'S Disease; Single-Cell Rna Sequencing
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease, presenting symptoms such as tremor and imbalance due to the loss of brain cells. Currently, no treatment exists for PD, but advancing technology continues to provide insight into the genetic basis of the disease. Here, I aim to develop a computational algorithm that facilitates the study of gene expression in PD for large sample sizes.
New technologies that differentiate pluripotent stem cells into specific cell types have advanced neurodegenerative disease research, but this differentiation process is currently unfeasible for large sample sizes. Pooling and differentiating cells from many samples in the same dish improves feasibility; however, the sample identity of all cells must then be determined. My algorithm will unravel the identity of pooled cells from unprecedented sample sizes.
As proof of principle, I will test the hypothesis that differentiating pooled cells, followed by gene expression analysis, can be used to determine transcriptional responses to chemical compounds in PD. Specifically, I will differentiate pooled cells from PD cases and controls into dopaminergic neurons or microglia. Then, I will treat the cells with chemical compounds that target known PD genetic pathways. Finally, I will use my algorithm to resolve each cell's identity and analyze differential gene expression between cases and controls.
My algorithm will make future single-cell gene expression analyses of large sample sizes feasible. Furthermore, I intend to show that the combination of my algorithm, pooled growth of patient-derived cells, and transcriptional analysis could be used to evaluate therapeutic compounds in PD, instituting the application of this methodology across neurodegenerative diseases.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fiorini, Michael R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~